Active Ingredient: NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Proprietary Name: SUMATRIPTAN AND NAPROXEN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;EQ 85MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090872
Product Number: 001
Approval Date: Sep 4, 2018
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
